drugset / Trial / NCT00349388
Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
To determine whether once a day administration of Mesalamine is at least as safe and efficacious and administration of multiple doses a day in preventing clinical relapse of ulcerative colitis in children and adolescence.
Timeline
- Start
- 2006-07
- Primary completion
- 2011-01
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mesalamine | Small molecule | — | — |